Obulytix (Private limited company)

ComBioNX
BE 0803.351.624 Active ●Suzanne Tassierstraat 1, 9052 Gand

Obulytix is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0803.351.624. It was founded on 29-06-2023. Its registered office is in Ghent. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 2 217 512 and a loss of € 2 664 969. These accounts report 4.3 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 2 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0803.351.624
VAT registered
Yes
Founded
29-06-2023
Latest accounts
2025
Employees
4.3 FTE
Region
Flanders
Establishments
1
Filing record
On time 2 of 2 years
Peppol e-invoicing
Registered
Registered office
Suzanne Tassierstraat 1, 9052 Gand
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21201 Fabrication de médicaments
72109 Recherche-développement en autres sciences physiques et naturelles

Key figures of Obulytix

20252024
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -2 664 969-146 %€ -1 081 154
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 217 512-42 %€ 3 820 634
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 5 294 677+4 %€ 5 101 630
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -2 121 140-259 %€ -590 450
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
4.3+65 %2.6

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
8 mandates on record in the annual accounts. 3 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Ghent.

CompanyTown
RNA Pioneering 9052 Gent
Eurofins Amatsigroup 9052 Gent
Taikun Pharmaceutical Technology 9052 Gent
APCOR R&M 9052 Gent
272BIO 9052 Gent
AVROXA 9052 Gent
ILiAD Biotechnologies 9052 Gent
AnimAb 9052 Gent
Looking for more information about Obulytix?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Obulytix still active? Yes. The Crossroads Bank for Enterprises lists Obulytix as active.

What is the VAT number of Obulytix? The VAT number of Obulytix is BE 0803.351.624.

When was Obulytix founded? Obulytix was founded on 29-06-2023.

What is the address of Obulytix? The current registered office of Obulytix is Suzanne Tassierstraat 1, 9052 Gand.

When did Obulytix last file annual accounts? The latest annual accounts of Obulytix were filed on 22-06-2026.

Does Obulytix file its annual accounts on time? Yes. Obulytix filed its annual accounts within the legal deadline for each of its last 2 financial years.

How many employees does Obulytix have? Obulytix employs 4.3 full-time equivalents according to its most recent annual accounts.

Is Obulytix financially healthy? Addrly gives Obulytix a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Obulytix profitable? The annual accounts of Obulytix for 2025 show a loss of € 2 664 969.

What is the equity of Obulytix? The equity of Obulytix was € 2 217 512 at the close of the 2025 financial year.

Who are the directors of Obulytix? The annual accounts of Obulytix record 8 mandates. The names, roles and dates are visible with a free account.

Can Obulytix receive Peppol e-invoices? Yes. Obulytix is registered on the Peppol network and can receive structured electronic invoices.

What does Obulytix do? The main activity of Obulytix is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data